Epigenetic developmental programs and adipogenesis: Implications for psychotropic induced obesity

Epigenetics

Volumn 8, Issue 11, 2013, Pages 1133-1140

  Chase, Kayla ^a   Sharma, Rajiv P ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

Epigenetics; Histone methylation; Obesity; Psychotropics; Schizophrenia

Indexed keywords

ANTIDEPRESSANT AGENT; CCAAT ENHANCER BINDING PROTEIN; CLOZAPINE; CYCLIC AMP; DOPAMINE RECEPTOR; FLUOXETINE; GLIPIZIDE; HALOPERIDOL; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE INHIBITOR; INSULIN; LITHIUM; NEUROPEPTIDE Y; OLANZAPINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; SEROTONIN 1A AGONIST; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; SULPIRIDE; TRICHOSTATIN A; VALPROIC ACID;

ADIPOCYTE; ADIPOGENESIS; ARTICLE; BODY FAT; DEMETHYLATION; DNA METHYLATION; ENZYME ACTIVITY; EPIGENETICS; FAT MASS; GENE EXPRESSION; GENETIC REGULATION; HISTONE ACETYLATION; HISTONE METHYLATION; HUMAN; IMMUNOREACTIVITY; LIPID STORAGE; NONHUMAN; OBESITY; SINGLE NUCLEOTIDE POLYMORPHISM; WEIGHT GAIN; WNT SIGNALING PATHWAY;

EPIGENETICS; HISTONE METHYLATION; OBESITY; PSYCHOTROPICS; SCHIZOPHRENIA;

ADIPOGENESIS; ANIMALS; ANTIDEPRESSIVE AGENTS; CELL DIFFERENTIATION; CELL PROLIFERATION; ENERGY METABOLISM; EPIGENESIS, GENETIC; HUMANS; MENTAL DISORDERS; METHYLATION; OBESITY; PSYCHOTROPIC DRUGS; TRANYLCYPROMINE; WNT SIGNALING PATHWAY;

EID: 84887441099     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.26027     Document Type: Article

References (63)

1. Dent R, Blackmore A, Peterson J, Habib R, Kay G P, Gervais A, Taylor V, Wells G. Changes in body weight and psychotropic drugs: a systematic synthesis of the literature. PLoS One 2012; 7:e36889; PMID:22719834; http://dx.doi.org/10.1371/jour-nal.pone.0036889
2. Patten SB, Williams JV, Lavorato DH, Brown L, McLaren L, Eliasziw M. Major depression, a ntidepres-sant medication and the risk of obesity. Psychother Psychosom 2009; 78:182-186; PMID:19321971; http://dx.doi.org/10.1159/000209349
3. Smits JA, Rosenfield D, Mather AA, Tart CD, Henriksen C, Sareen J. Psychotropic medication use mediates the relationship between mood and anxiety disorders and obesity: findings from a nationally representative sample. J Psychiatr Res 2010; 44:1010-1016; PMID:20434171; http://dx.doi.org/10.1016/j. jpsychires.2010.04.007
4. Klemp M, Tvete IF, Skomedal T, Gaasemyr J, Natvig B, Aursnes I. A review and Bayesian meta-analysis of clinical efficacy and adverse effects of 4 atypical neuroleptic drugs compared with haloperidol and placebo. J Clin Psychopharmacol 2011; 31:698-704; PMID:22020356; http://dx.doi.org/10.1097/ JCP.0b013e31823657d9
5. Jin H, Shih PA, Golshan S, Mudaliar S, Henry R, Glorioso DK, Arndt S, Kraemer HC, Jeste DV. Comparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomization. J Clin Psychiatry 2013; 74:10-18; PMID:23218100; http:// dx.doi.org/10.4088/JCP.12m08001
6. Heitmann BL, Garby L. Patterns of long-term weight changes in overweight developing Danish men and women aged between 30 and 60 years. Int J Obes Relat Metab Disord 1999; 23:1074-1078; PMID:10557028; http://dx.doi.org/10.1038/sj.ijo.0801035
7. Leslie WS, Hankey CR, Lean ME. Weight gain as an adverse effect of some commonly prescribed drugs: a systematic review. Q JM 2007; 100:395-404; PMID:1756 6010; http://dx.doi.org/10.1093/qjmed/ hcm044
8. Spalding KL, Arner E, Westermark PO, Bernard S, Buchholz BA, Bergmann O, Blomqvist L, Hoffstedt J, Näslund E, Britton T, et al. Dynamics of fat cell turnover in humans. Nature 2008; 453:783-787; PMID:18454136; http://dx.doi.org/10.1038/ nature06902
9. Peng L, Jia Z, Yin X, Zhang X, Liu Y, Chen P, Ma K, Zhou C. Comparative analysis of mesenchymal stem cells from bone marrow, cartilage, and adipose tissue. Stem Cells Dev 2008; 17:761-773; PMID:18393634; http://dx.doi.org/10.1089/scd.2007.0217
10. Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL, MacDougald OA. Inhibition of adipogenesis by Wnt signaling. Science 2000; 289:950-953;PMID:10937998; http://dx.doi. org/10.1126/science.289.5481.950
11. Tateishi K, Okada Y, Kallin EM, Zhang Y. Role of Jhdm2a in regulating metabolic gene expression and obesity resistance. Nature 2009; 458:757-761; PMID: 19194461; http://dx.doi.org/10.1038/ nature07777
12. Pavan C, Vindigni V, Michelotto L, Rimessi A, Abatangelo G, Cortivo R, Pinton P, Zavan B. Weight gain related to treatment with atypical antipsychotics is due to activation of PKC-(3. Pharmacogenomics J 2010; 10:408-417; PMID:20029385; http://dx.doi. org/10.1038/tpj.2009.67
13. Hemmrich K, Gummersbach C, Pallua N, Luckhaus C, Fehsel K. Clozapine enhances differentiation of adipocyte progenitor cells. Mol Psychiatry 2006; 11:980-981; PMID:17063181; http://dx.doi. org/10.1038/sj.mp.4001892
14. Fajas L, Schoonjans K, Gelman L, Kim JB, Najib J, Martin G, Fruchart JC, Briggs M, Spiegelman BM, Auwerx J. Regulation of peroxisome proliferator-acti-vated receptor gamma expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: implications for adipocyte differentiation and metabolism. Mol Cell Biol 1999; 19:5495-503; PMID:10409739
15. Kim JB, Wright HM, Wright M, Spiegelman BM. ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand. Proc Natl Acad Sci USA 1998; 95:4333-4337; PMID:9539737; http:// dx.doi.org/10.1073/pnas.95.8.4333
16. Yang LH, Chen TM, Yu ST, Chen YH. Olanzapine induces SREBP-1-related adipogen-esis in 3T3-L1 cells. Pharmacol Res 2007; 56:202-208; PMID: 17651982; http://dx.doi.org/10.1016/j. phrs.2007.05.007
17. Yang Z, Yin JY, Gong ZC, Huang Q, Chen H, Zhang W, Zhou HH, Liu ZQ. Evidence for an effect of clozapine on the regulation of fat-cell derived factors. Clin Chim Acta 2009; 408:98-104; PMID:19682446; http://dx.doi.org/10.1016/j. cca.2009.07.021
18. Fernø J, Vik-Mo AO, Jassim G, Håvik B, Berge K, Skrede S, Gudbrandsen OA, Waage J, Lunder N, Mørk S, et al. Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver. Psychopharmacology (Berl) 2009; 203:73-84; PMID:18989661; http://dx.doi. org/10.1007/s00213-008-1370-x
19. Rosen ED, MacDougald OA. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 2006; 7:885-896; PMID:17139329; http://dx.doi. org/10.1038/nrm2066
20. Sugii S, Evans RM. Epigenetic codes of PPARγ in metabolic disease. FEBS Lett 2011; 585:2121-2128; PMID:21605560; http://dx.doi.org/10.1016/j. febslet.2011.05.007
21. Tamori Y, Masugi J, Nishino N, Kasuga M. Role of peroxisome proliferator-activated receptor-gamma in maintenance of the characteristics of mature 3T3-L1 adipocytes. Diabetes 2002; 51:2045-2055; PMID: 12086932; http://dx.doi.org/10.2337/ diabetes.51.7.2045
22. Imai T, Takakuwa R, Marchand S, Dentz E, Bornert JM, Messaddeq N, Wendling O, Mark M, Desvergne B, Wahli W, et al. Peroxisome prolifera-tor-activated receptor gamma is required in mature white and brown adipocytes for their survival in the mouse. Proc Natl Acad Sci U S A 2004; 101:4543-4547; PMID: 15070754; http://dx.doi.org/10.1073/ pnas.0400356101
23. Couturier J, Patel SG, Iyer D, Balasubramanyam A, Lewis DE. Human monocytes accelerate proliferation and blunt differentiation of preadipocytes in association with suppression of C/EBPA mRNA. Obesity (Silver Spring) 2012; 20:253-262; PMID:21869759; http://dx.doi.org/10.1038/oby.2011.275
24. Musri MM, Gomis R, Párrizas M. A chromatin perspective of adipogenesis. Organogenesis 2010; 6:15-23; PMID:20592861; http://dx.doi.org/10.4161/ org.6.1.10226
25. Fajas L, Egler V, Reiter R, Hansen J, Kristiansen K, Debril MB, Miard S, Auwerx J. The retinoblastoma-histone deacetylase 3 complex inhibits PPARgamma and adipocyte differentiation. Dev Cell 2002; 3:903-910; PM I D:12 47 9 814; http://dx.doi.org/10.1016/ S1534-5807(02)00360-X
26. Sharma RP. Schizophrenia, epigenetics and ligand-activated nuclear receptors: a framework for chro-matin therapeutics. Schizophr Res 2005; 72:79-90; PM I D: 15 5 6 0 9 5 4; http://dx.doi.org/10.1016/j. schres.2004.03.001
27. Sharma RP, Gavin DP, Grayson DR. CpG meth-ylation in neurons: message, memory, or mask? Neuropsychopharmacology 2010; 35:2009-2020; PMID:20631690; http://dx.doi.org/10.1038/ npp.2010.85
28. Sharma R P, Gavin DP, Chase KA. Heterochromatin as an incubator for pathology and treatment non-response: implication for neuropsychiat-ric illness. Pharmacogenomics J 2012; 12:361-367; PMID:22249356; http://dx.doi.org/10.1038/ tpj. 2011.6 4
29. Sharma R P, Chase KA. Increasing neuronal 'stem-ness': chromatin relaxation and the expression of reprogramming genes in post-mitotic neurons. Med Hypotheses 2012; 78:553-554; PMID:22326495; http://dx.doi.org/10.1016/j.mehy.2011.12.018
30. Musri MM, Corominola H, Casamitjana R, Gomis R, Párrizas M. Histone H3 lysine 4 dimethylation signals the transcriptional competence of the adi-ponectin promoter in preadipocytes. J Biol Chem 2006; 281:17180-17188; PMID:16613853; http://dx.doi. org/10.1074/jbc.M601295200
31. Yoo EJ, Chung JJ, Choe SS, Kim KH, Kim JB. Down-regulation of histone deacetylases stimulates adipo-cyte differentiation. J Biol Chem 2006; 281:6608-6615; PMID:16407282; http://dx.doi.org/10.1074/jbc. M508982200
32. Couturier J, Patel SG, Iyer D, Balasubramanyam A, Lewis DE. Human monocytes accelerate proliferation and blunt differentiation of preadipocytes in association with suppression of C/EBP0391; mRNA. Obesity (Silver Spring) 2012; 20:253-262; PMID:21869759; http://dx.doi.org/10.1038 /oby.2011.275
33. Fujiki K, Kano F, Shiota K, Murata M. Expression of the peroxisome proliferator activated receptor gamma gene is repressed by DNA methylation in visceral adipose tissue of mouse models of diabetes. BMC Biol 2009; 7:38-7007.
34. Wang L, Xu S, Lee JE, Baldridge A, Grullon S, Peng W, Ge K. Histone H3K9 methyltransferase G9a represses PPARγ expression and adipogenesis. EMBO J 2013; 32:45-59; PMID:23178591; http://dx.doi. org/10.1038/emboj.2012.306
35. Mann J, Chu DC, Maxwell A, Oakley F, Zhu NL, Tsukamoto H, Mann DA. MeCP2 controls an epi-genetic pathway that promotes myofibroblast trans-differentiation and fibrosis. Gastroenterology 2010; 138:705-714.
36. Takada I, Mihara M, Suzawa M, Ohtake F, Kobayashi S, Igarashi M, Youn MY, Takeyama K, Nakamura T, Mezaki Y, et al. A histone lysine methyltransfer-ase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation. Nat Cell Biol 2007; 9:1273-1285; PMID:179520 62; http://dx.doi. org/10.1038/ncb1647
37. Wiper-Bergeron N, Wu D, Pope L, Schild-Poulter C, Haché RJ. Stimulation of preadipocyte differentiation by steroid through targeting of an HDAC1 complex. EMBO J 2003; 22:2135-45; PMID:12727880; http://dx.doi.org/10.1093/emboj/cdg218
38. Inagaki T, Tachibana M, Magoori K, Kudo H, Tanaka T, Okamura M, Naito M, Kodama T, Shinkai Y, Sakai J. Obesity and metabolic syndrome in his-tone demethylase JHDM2a-deficient mice. Genes Cells 2009; 14:991-1001; PMID:19624751; http:// d x.doi.org /10.1111/j.1365 -24 43. 20 09.0132 6.x
39. Lee J, Saha PK, Yang QH, Lee S, Park JY, Suh Y, Lee SK, Chan L, Roeder RG, Lee JW. Targeted inacti-vation of MLL3 histone H3-Lys-4 methyltransferase activity in the mouse reveals vital roles for MLL3 in adipogenesis. Proc Natl Acad Sci U S A 2008; 105:19229-19234; PMID:19047629; http://dx.doi. org/10.1073/pnas.0810100105
40. Cho YW, Hong S, Jin Q, Wang L, Lee JE, Gavrilova O, Ge K. Histone methylation regulator PTIP is required for PPARgamma and C/EBPalpha expression and adipogenesis. Cell Metab 2009; 10:27-39; PMID:19583951; http://dx.doi.org/10.1016/j. cmet.2009.05.010
41. Hino S, Sakamoto A, Nagaoka K, Anan K, Wang Y, Mimasu S, Umehara T, Yokoyama S, Kosai K, Nakao M. FAD-dependent lysine-specific demethylase-1 regulates cellular energy expenditure. Nat Commun 2012; 3:758; PMID:22453831; http://dx.doi. org/10.1038/ncomms1755
42. Ge K. Epigenetic regulation of adipogenesis by his-tone methylation. Biochim Biophys Acta 2012; 1819: 727-732.
43. Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL, MacDougald OA. Inhibition of adipogenesis by Wnt signaling. Science 2000; 289:950-953;PMID:10937998; http://dx.doi. org/10.1126/science.289.5481.950
44. Wang L, Jin Q, Lee JE, Su IH, Ge K. Histone H3K27 methyltransferase Ezh2 represses Wnt genes to facilitate adipogenesis. Proc Natl Acad Sci U S A 2010; 107:7317-7322; PMID:20368440; http://dx.doi. org/10.1073/pnas.1000031107
45. Noer A, Sørensen AL, Boquest AC, Collas P. Stable CpG hypomethylation of adipogenic promoters in freshly isolated, cultured, and differentiated mesen-chymal stem cells from adipose tissue. Mol Biol Cell 2006; 17:3543-3556; PMID:16760426; http://dx.doi. org/10.1091/mbc.E06-04-0322
46. Sharma R P. Schizophrenia, epigenetics and ligand-activated nuclear receptors: a framework for chro-matin therapeutics. Schizophr Res 2005; 72:79-90; PM I D: 155 6 0 9 5 4; http://dx.doi.org/10.1016/j. schres.2004.03.001
47. Dong E, Grayson DR, Guidotti A, Costa E. Antipsychotic subtypes can be characterized by differences in their ability to modify GABAergic promoter methylation. Epigenomics 2009; 1:201-211; PMID:22122643; http://dx.doi.org/10.2217/ epi.09.2
48. Kim SH, Lee HY, Yi H, Ahn YM, Kim YS. Haloperidol induces demethylation and expression of the dual specificity phosphatase 6 gene in MIA PaCa-2 human pancreatic cancer cells. Life Sci 2012; 91:1317-1322; PMID:23063941; http://dx.doi. org/10.1016/j.lfs.2012.10.002
49. Shimabukuro M, Jinno Y, Fuke C, Okazaki Y. Haloperidol treatment induces tissue- and sex-specific changes in DNA methylation: a control study using rats. Behav Brain Funct 2006; 2:37; P M I D: 17 1 3 2176; ht tp://d x.doi.org/10.1186/174 4-9081-2-37
50. Sani G, Napoletano F, Forte AM, Kotzalidis GD, Panaccione I, Porfiri GM, Simonetti A, Caloro M, Girardi N, Telesforo CL, et al. The wnt pathway in mood disorders. Curr Neuropharmacol 2012; 10:239-253; PMID:234 49817; http://dx.doi. org /10.2174 /157015912803217279
51. Sutton LP, Honardoust D, Mouyal J, Rajakumar N, Rushlow WJ. Activation of the canonical Wnt pathway by the antipsychotics haloperidol and clo-zapine involves dishevelled-3. J Neurochem 2007; 102:153 -169; PM ID:17472703; http://dx.doi. or g /10.1111/j.1471- 4159. 2 0 07. 0 452 7. x
52. Borcherding DC, Hugo ER, Idelman G, De Silva A, Richtand NW, Loftus J, Ben-Jonathan N. Dopamine receptors in human adipocytes: expression and functions. PLoS One 2011; 6:e25537; PMID:21966540; http://dx.doi.org/10.1371/journal.pone.0025537
53. Sachs GS, Guille C. Weight gain associated with use of psychotropic medications. J Clin Psychiatry 1999; 60(Suppl 21):16-19; PMID:10548137
54. Dong E, Nelson M, Grayson DR, Costa E, Guidotti A. Clozapine and sulpiride but not haloperidol or olan-zapine activate brain DNA demethylation. Proc Natl Acad Sci U S A 2008; 105:13614-13619; PMID:18757738; http://dx.doi.org/10.1073/pnas.0805493105
55. Li J, Guo Y, Schroeder FA, Youngs RM, Schmidt TW, Ferris C, Konradi C, Akbarian S. Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling. J Neurochem 2004; 90:1117-1131; PM I D: 1531 2167; http://dx.doi. o r g/10.1111/ j.14 71- 4159. 2 0 0 4. 0 25 69. x
56. Halene TB, Siegel SJ. PDE inhibitors in psychia-try--future options for dementia, depression and schizophrenia? Drug Discov Today 2007; 12:870-878; PMID:17933689; http://dx.doi.org/10.1016/j. drudis.2007.07.023
57. Baba A, Ohtake F, Okuno Y, Yokota K, Okada M, Imai Y, Ni M, Meyer CA, Igarashi K, Kanno J, et al. PKA-dependent regulation of the histone lysine demethylase complex PHF2-ARID5B. Nat Cell Biol 2011; 13: 668-75; PMID:21532585; http://dx.doi. org/10.1038/ncb2228
58. Ha CH, Kim JY, Zhao J, Wang W, Jhun BS, Wong C, Jin ZG. PK A phosphorylates histone deacety-lase 5 and prevents its nuclear export, leading to the inhibition of gene transcription and cardiomyo-cyte hypertrophy. Proc Natl Acad Sci USA 2010; 107:15467-15472; PMID:20716686; http://dx.doi. org/10.1073/pnas.1000462107
59. Cassel S, Carouge D, Gensburger C, Anglard P, Burgun C, Dietrich JB, Aunis D, Zwiller J. Fluoxetine and cocaine induce the epigenetic factors MeCP2 and MBD1 in adult rat brain. Mol Pharmacol 2006; 70: 487-492; PMID:16670375; http://dx.doi. org/10.1124/mol.106.022301
60. Maya Vetencourt JF, Tiraboschi E, Spolidoro M, Castrén E, Maffei L. Serotonin triggers a transient epigenetic mechanism that reinstates adult visual cortex plasticity in rats. Eur J Neurosci 2011; 33:49-57; PM I D: 2115 6 0 0 2; http://dx.doi. org/10.1111/j.1460-9568.2010.07488.x
61. O'Rahilly S. Human genetics illuminates the paths to metabolic disease. Nature 2009; 462:307-314; PMID:19924209; http://dx.doi.org/10.1038/ nature08532
62. Willer CJ, Speliotes EK, Loos RJ, Li S, et al., Genetic Investigation of Anthropometric Traits Consortium. Six new loci associated.
63. Obuchowicz E, Krysiak R, Herman ZS. Does neuro-peptide Y (NPY) mediate the effects of psychotropic drugs? Neurosci Biobehav Rev 2004; 28:595-610; P M I D: 1552 78 65; http://dx.doi.org/10.1016/j. neubiorev.2004.08.006